Lactulose and Veklury drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lactulose (lactulose) and Veklury (remdesivir). Common drug interactions include dermatitis allergic among females and bradycardia among males.
The phase IV clinical study analyzes what interactions people have when they take Lactulose and Veklury. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Lactulose?
Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.
What is Veklury?
Veklury has active ingredients of remdesivir. eHealthMe is studying from 2,753 Veklury users. Check the latest studies of Veklury.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
11 people who take Lactulose and Veklury together, and have interactions are studied.

What are the common drug interactions of Lactulose and Veklury, by gender? *:
female:
- Dermatitis allergic (inflammation of the skin due allergic reaction)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Death
- Urticaria (rash of round, red welts on the skin that itch intensely)
male:
- Bradycardia (abnormally slow heart action)
- Liver injury
- Pneumonia
- Retroperitoneal haematoma (blood clot between the peritoneum and the posterior abdominal wall)
- Septic shock (shock due to blood infection)
- Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
- Swelling
- Hepatocellular injury (liver injury)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Renal impairment (severely reduced kidney function)
What are the common drug interactions of Lactulose and Veklury, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Liver injury
40-49:
n/a
50-59:
- Hyperglycaemia (high blood sugar)
- Hyperkalaemia (damage to or disease of the kidney)
- Hypotension (abnormally low blood pressure)
- Iron deficiency
- Lactic acidosis (low ph in body tissues)
- Liver injury
- Pneumonia
- Retroperitoneal haematoma (blood clot between the peritoneum and the posterior abdominal wall)
- Septic shock (shock due to blood infection)
- Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
60+:
- Bradycardia (abnormally slow heart action)
- Dermatitis allergic (inflammation of the skin due allergic reaction)
- Hepatocellular injury (liver injury)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Death
- Urticaria (rash of round, red welts on the skin that itch intensely)
What are the existing conditions these people have? *
- Urination - Excessive Volume: 1 person, 9.09%
- Liver Disorder (liver diseases): 1 person, 9.09%
- Hypokalemia (low potassium): 1 person, 9.09%
- Hyperammonaemia: 1 person, 9.09%
- Hepatitis C: 1 person, 9.09%
- Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 1 person, 9.09%
- Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 9.09%
- Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 9.09%
- Gastric Ulcer (stomach ulcer): 1 person, 9.09%
- Gastric Disorder (disease of stomach): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Lactulose and Veklury?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lactulose and Veklury:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lactulose:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Veklury:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lactulose and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Veklury and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lactulose and remdesivir (the active ingredients of Lactulose and Veklury, respectively), and Lactulose and Veklury (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Flonase cause Hypothermia? - 10 seconds ago
- Could Omeprazole cause Listless? - 15 seconds ago
- Could Niacin cause Feeling Jittery? - 15 seconds ago
- Esomeprazole Magnesium and Cardiospasm for Men aged 40-49 - 15 seconds ago
- Could Gabapentin cause Mucosal Haemorrhage? - 17 seconds ago
- Could Rifampin cause Dizziness? - 50 seconds ago
- Ulcerative Colitis and drugs of ingredients of trazodone hydrochloride - a minute ago
- Ginkgo Biloba and Vitamin D3 drug interactions for women aged 40-49 - a minute ago
- Could Mirtazapine cause Drug Ineffective? - a minute ago
- Drug interactions of Bosulif and Sprycel - a minute ago